224
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT

Comparison of Ablation Volume Between Emprint® and Mimapro® Systems for Hepatocellular Carcinoma –A Preliminary Study

ORCID Icon, , , , , , , , , , , & ORCID Icon show all
Pages 979-985 | Received 29 Mar 2023, Accepted 31 May 2023, Published online: 22 Jun 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249.
  • Kudo M, Kawamura Y, Hasegawa K, et al. Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update. Liver Cancer. 2021;10(3):181–223. Epub 2021 May 19. PMID: 34239808. doi:10.1159/000514174
  • Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.
  • Poulou LS, Botsa E, Thanou I, et al. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol. 2015;7:1054–1063. doi:10.4254/wjh.v7.i8.1054
  • Cornelis FH, Marcelin C, Bernhard JC. Microwave ablation of renal tumors: a narrative review of technical considerations and clinical results. Diagn Interv Imaging. 2017;98:287–297. doi:10.1016/j.diii.2016.12.002
  • Brace CL. Microwave tissue ablation: biophysics, technology, and applications. Crit Rev Biomed Eng. 2010;38(1):65–78. doi:10.1615/CritRevBiomedEng.v38.i1.60
  • Ahmed M, Solbiati L, Brace CL; International Working Group on Image-guided Tumor Ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology. 2014;273(1):241–260. Epub 2014 Jun 13. PMID: 24927329. doi:10.1148/radiol.14132958
  • Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199–S202. doi:10.1097/01.RVI.0000094584.83406.3e
  • Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458. PMID: 23208313. doi:10.1038/bmt.2012.244
  • Rizzo A, Ricci AD, Di Federico A, et al. Predictive biomarkers for checkpoint inhibitor-based immunotherapy in Hepatocellular Carcinoma: where do we stand? Front Oncol. 2021;11:803133. PMID: 34976841. doi:10.3389/fonc.2021.803133
  • Viscardi G, Tralongo AC, Massari F, et al. Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis. Eur J Cancer. 2022;177:175–185. PMID: 36368251. doi:10.1016/j.ejca.2022.09.031
  • Di Federico A, Rizzo A, Carloni R, et al. Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials. Expert Opin Investig Drugs. 2022;31:361–369. PMID: 34798793. doi:10.1080/13543784.2022.2009455
  • Rizzo A, Cusmai A, Gadaleta-Caldarola G, et al. Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma? Expert Rev Gastroenterol Hepatol. 2022;16(4):333–339. PMID: 35403533. doi:10.1080/17474124.2022.2064273
  • Abdelaziz AO, Nabeel MM, Elbaz TM, et al. Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis. Scand J Gastroenterol. 2015;50:479–484. doi:10.3109/00365521.2014.1003397
  • Zaidi N, Okoh A, Yigitbas H, et al. Laparoscopic microwave thermosphere ablation of malignant liver tumors: an analysis of 53 cases. J Surg Oncol. 2016;113(2):130–134. doi:10.1002/jso.24127
  • Itoh S, Ikeda Y, Kawanaka H, et al. Efficacy of surgical microwave therapy in patients with unresectable hepatocellular carcinoma. Ann Surg Oncol. 2011;18(13):3650–3656. doi:10.1245/s10434-011-1831-z
  • Berber E. Laparoscopic microwave thermosphere ablation of malignant liver tumors: an initial clinical evaluation. Surg Endosc. 2016;30(2):692–698. doi:10.1007/s00464-015-4261-3
  • Facciorusso A, Abd El Aziz MA, Tartaglia N, et al. Microwave ablation versus radiofrequency ablation for treatment of Hepatocellular Carcinoma: a meta-analysis of randomized controlled trials. Cancers. 2020;12(12):3796. doi:10.3390/cancers12123796
  • Poggi G, Tosoratti N, Montagna B, Picchi C. Microwave ablation of hepatocellular carcinoma. World J Hepatol. 2015;7:2578–2589. doi:10.4254/wjh.v7.i25.2578
  • Bleicher RJ, Allegra DP, Nora DT, et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol. 2003;10:52–58. doi:10.1245/ASO.2003.03.018
  • Crocetti L, de Baere T, Lencioni R. Quality improvement guide-lines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11–17. doi:10.1007/s00270-009-9736-y
  • Wright AS, Sampson LA, Warner TF, et al. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236:132–139. doi:10.1148/radiol.2361031249
  • Awad MM, Devgan L, Kamel IR, et al. Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings. HPB. 2007;9(5):357–362. doi:10.1080/13651820701646222
  • Yu J, Liang P, Yu X, et al. A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol. 2011;79(1):124–130. doi:10.1016/j.ejrad.2009.12.009